Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction
Kazuo Kimura(Yokohama City University Medical Center), Atsushi Hirayama(Nihon University), Akira Kaneko(Karolinska Institutet), Masanori Asakura(National Cerebral and Cardiovascular Center), Masami Kosuge, Hajime Sakuma, Masaharu Ishihara(Hyogo Medical University), Yasuharu Nakama(City Hospital), Kōichi Nakao(Kanazawa Seiryo University), Naoya Matsumoto(Osaka University), Takahito Sone(Ogaki Municipal Hospital), Takafumi Hiro(Institute for Atherosclerosis Research), Tadateru Takayama(Nihon University), Yoshisato Shibata, Shigeru Fukuzawa(Funabashi Municipal Medical Center), Chikuma Hamada(Tokyo University of Science), Haruo Hirayama(Japanese Red Cross Nagoya Daini Hospital), Toshiaki Yokoi(TOA EIYO (Japan))
Cited by 12
Related Papers
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
|Journal of Atherosclerosis and Thrombosis|2013|469